Potential anti-viral activity of approved repurposed drug against main protease of SARS-CoV-2: an in silico based approach
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Potential anti-viral activity of approved repurposed drug against main protease of SARS-CoV-2: an in silico based approach
Authors
Keywords
-
Journal
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
Volume -, Issue -, Pages 1-10
Publisher
Informa UK Limited
Online
2020-05-14
DOI
10.1080/07391102.2020.1768902
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Coronavirus Infections—More Than Just the Common Cold
- (2020) Catharine I. Paules et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines
- (2020) Xin Liu et al. Journal of Genetics and Genomics
- An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study
- (2020) Sourav Das et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Peptide-like and small-molecule inhibitors against Covid-19
- (2020) Suyash Pant et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin
- (2020) Anwarul Hasan et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- An in-silico evaluation of different Saikosaponins for their potency against SARS-CoV-2 using NSP15 and fusion spike glycoprotein as targets
- (2020) Saurabh K. Sinha et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Moroccan Medicinal plants as inhibitors against SARS-CoV-2 main protease: Computational investigations
- (2020) I. Aanouz et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment
- (2020) Subramanian Boopathi et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19
- (2020) Nisha Muralidharan et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Stilbene-based natural compounds as promising drug candidates against COVID-19
- (2020) Hussain Mustatab Wahedi et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Drug repurposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes
- (2020) Ammar D. Elmezayen et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target
- (2020) Umesh et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Reverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: an in silico study
- (2020) Maryam Enayatkhani et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach
- (2020) Sukanth Kumar Enmozhi et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain)
- (2020) Phulen Sarma et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
- (2020) Zhenming Jin et al. NATURE
- The proximal origin of SARS-CoV-2
- (2020) Kristian G. Andersen et al. NATURE MEDICINE
- WHO launches global megatrial of the four most promising coronavirus treatments
- (2020) Kai Kupferschmidt SCIENCE
- Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases
- (2020) Cynthia Liu et al. ACS Central Science
- Viral dynamics in mild and severe cases of COVID-19
- (2020) Yang Liu et al. LANCET INFECTIOUS DISEASES
- Multiple-targets Directed Screening of Flavonoid Compounds from Citrus Species to find out Antimalarial Lead with Predicted Mode of Action: An In Silico and Whole Cell-based In vitro Approach
- (2019) Neelutpal Gogoi et al. Current Computer-Aided Drug Design
- Flexible docking-based molecular dynamics simulation of natural product compounds and Ebola virus Nucleocapsid (EBOV NP): a computational approach to discover new drug for combating Ebola
- (2018) Mochammad Arfin Fardiansyah Nasution et al. BMC BIOINFORMATICS
- Molecular mechanism of viomycin inhibition of peptide elongation in bacteria
- (2016) Mikael Holm et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SARS-CoV 3CL protease cleaves its C-terminal autoprocessing site by novel subsite cooperativity
- (2016) Tomonari Muramatsu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In Silico Docking, Molecular Dynamics and Binding Energy Insights into the Bolinaquinone-Clathrin Terminal Domain Binding Site
- (2014) Mohammed Abdel-Hamid et al. MOLECULES
- Molecular dynamics simulations and drug discovery
- (2011) Jacob D Durrant et al. BMC BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation